Introduction
Acute kidney injury (AKI) is observed in up to 30% of children admitted to pediatric intensive care units (PICUs) and is associated with a mortality rate of up to 50%. [1] [2] [3] There is evidence that the epidemiology of pediatric AKI has changed over the past few decades and that primary renal diseases are currently no longer the most common causes of AKI. 4 Nowadays, the most frequent causes of AKI in developed countries are acute tubular necrosis, nephrotoxic medications, oncological diseases, septic shock, and their common consequence -multi-organ-failure (MOF). 5 Over the past 2 decades, in many developed countries, continuous renal replacement therapy (CRRT) has become the most widely used renal support modality in critically ill children. 6 It eliminates the need for fluid restriction and allows for the provision of medications, blood products and nutrition in critically ill children. 7 Despite the increasing use of CRRT, AKI is associated with an increased risk of mortality in critically ill patients. 8, 9 Although formal and clearly defined indications for CRRT use are lacking, it is mostly employed for individual AKI and AKI associated with fluid overload (FO), MOF and sepsis. 10 Furthermore, there are still not many published reports addressing CRRT in PICUs. 6 The main objective of the present study was to evaluate the clinical course, to analyze factors associated with the outcome and to identify prognostic factors in critically ill children receiving CRRT.
Material and methods
This was a retrospective, single-center, chart review study, including 46 patients receiving CRRT, who had been admitted to the PICU in the Department of Anesthesiology and Intensive Care, Institute of Pediatrics, Jagiellonian University Medical College, Kraków, Poland, between January 2009 and December 2016. This study was approved by the Bioethical Committee of Cracow Medical Chamber (OIL/KBL/4/2017).
Initiation, prescription and general CRRT management occurred under the guidance of the attending intensivist and consulting nephrologist. The primary indications for the initiation of CRRT were categorized as AKI, FO or MOF. Fluid overload percentage (FO%) was determined using the PICU admission weight in kilograms as the baseline weight for comparison. The FO% was defined using the method described by Goldstein et al. ( [fluid in -fluid out]/[intensive care unit admission weight] × 100%), and fluid in (or out) was considered to be the amount of fluid from admission to PICU to CRRT initiation. 11 Acute kidney injury was determined by the pediatric-modified Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease score (RIFLE, modified into p-RIFLE). 2 Multi-organ failure was defined as the presence of at least 2 organs involved at any time on admission to PICU. 12 Sepsis was defined using the criteria of the International Consensus Conference on Pediatric Sepsis. 12 A Prismaflex dialysis machine (Gambro, Barcelona, Spain) was used for CRRT in all the patients. Dual lumen catheters were used depending on the age, weight and morphology of the child, using the same criteria for the patients treated with regional citrate anticoagulation (RCA) and heparin anticoagulation (Hep-ACG). 8, 13 Hollow fiber hemofilters were used depending on the body weight of the patient, according to the guidelines of the manufacturer. 14 In all the Hep-ACG cases, predilutional continuous veno-venous hemodiafiltration (CVVHDF) was employed and unfractionated heparin (Hep) was used. In the Hep-ACG protocol, a Hep bolus was administered during the connection along with a subsequent continuous Hep infusion to achieve a post-filter activated clotting time (ACT) between 180 and 240 s. The ACT value was checked on average every 2 h within the first 12 h of CRRT, and then every 4-6 h.
The RCA procedure was conducted according to the guidelines from the study by Tolwani et al. and from the Prismaflex operator's manual. 14, 15 An initial citrate concentration of 3.0 mmol/L was used for a target post-filter ionized calcium level of 0.25-0.50 mmol/L. The citrate effect was neutralized using a continuous calcium infusion of 10% calcium gluconate (or 5% in children weighing <15 kg) to maintain ionized calcium blood levels between 1.0 and 1.2 mmol/L. 15, 16 Samples were taken every hour for the first 4 h and every 6-8 h afterwards. Total calcium levels were also checked at least once daily. Citrate accumulation was avoided by monitoring the patient's pH status and by total calcium/ionic calcium index (CaT/CaI) being maintained ≤2.5.
Regarding the CRRT solutions for Hep-ACG, Hemosol, or PrismaSol 2 (Gambro) as a dialyzate and Phoxilium (Gambro) or PrismaSol 2 as a predilutional substitute were used; whereas for RCA, the citrate solution Prismocitrate 18/0 (Gambro) was administered in a pre-blood pump (PBP), the dialyzate normocarbonate solution PrismOcal B22 (Gambro) was used as a calcium-free dialysis solution, and the low-flow post-filter infusion of PrismaSol 2 or Phoxillum was employed as a postdilutional substitute to avoid clotting in the deaeration chamber return line.
In both techniques, the dialyzate and substitution flow rates were initially programmed to achieve a dialysis dose of at least 35 mL/kg/h and were subsequently adjusted in an ongoing manner to meet the patients' needs. None of the filters were used for longer than 72 h. The blood flow rates (BFR) were determined according to the patients' body mass and were monitored by the pressure at the access sites. 15 Dual lumen catheters were individually adapted to the child's morphology and body weight according to the literature recommendations. 8, 13 The implantation sites of the 
Statistical analysis
The distribution of polytomous variables was described employing the mean value, standard deviation (SD), median value, and interquartile range (IQR). To compare the distributions, Student's t-test was used, providing the Kolmogorov-Smirnov (KS) test yielded a positive result for conformity of the empirical distribution and Gaussian distribution. In case of a lack of such conformity, the Wilcoxon rank-sum test (equivalent to the Mann-Whitney U test) was employed; this fact was indicated by marking the appropriate p-value with an asterisk (*). The sample sizes were compared by means of the χ 2 test; in the cases with low predicted frequencies, Yates's modification was employed, which was indicated by marking the appropriate p-values with 2 asterisks (**). The effect of FO% on the cumulative survival probability of the patients was analyzed employing the Kaplan-Meier curves and the Mantel-Cox test. Additionally, the univariate and multivariate analyses of significant parameters were carried out depending on ACG and the outcome. In addition, the univariable and multivariable logistic regression analyses were performed, identifying the parameters showing a significant odds ratio (OR) and describing the effect on the outcome. When only dichotomous input variables were considered, the OR was computed directly from the contingency table analysis. It should be emphasized that depending on the employed mode of analysis, the numerical assessment of the effect of a given parameter on the outcome was achieved in the form of probability of death (mortality) or OR of death (mortality OR). In all tests, the significance threshold was assumed to be 0.05, with the exception of the KS test, where a value of 0.1 was assumed to be significant. The STATISTICA v. 12 (StatSoft Inc., Tulsa, USA) and MATLAB v. 2015a (Mathworks, Natick, USA) packages were used for all calculations and for creating the graphs.
Results
The number of children requiring CRRT in particular years was as follows: A detailed characteristics of the study population is included in Tables 1 and 2 . The main diagnoses in the studied population were as follows: 1. oncological diseases -20 children (43.5%), including acute lymphoblastic leukemia -11 (8 after bone marrow transplantation (BMT)), lymphoma -3, solid tumors -3, and acute myeloid leukemia after BMT -3; 2. hematological diseases -6 children (13%), including aplastic anemia after BMT -3, severe combined immunodeficiency after BMT -2 and hemophagocytic syndromes after BMT -1; 3. nephrological diseases -11 children (24%), including chronic kidney disease (CKD) exacerbation -4, chronic dialysis complications -3, rapid progressive glomerulonephritis -1, hemolytic uremic syndrome -2, and tubulointerstitial nephritis -1; 4. sepsis -3 children (6.5%), including Neisseria meningitidis -2 and Streptococcus spp. -1; 5. burns -2 children (4.3%); 6. cardiovascular diseases -2 children (4.3%); 7. rheumatic disease (systemic lupus erythematosus) -1 child (2.2%); and 8. gastroenterological diseases -1 child (2.2%).
There were no statistically significant differences in the ratio of the main diagnoses, neither between Hep-ACG and RCA, nor between deceased and surviving patients (apart from nephrological diagnoses in the case of deceased vs surviving patients: 1 vs 10; p = 0.001).
While comparing the sample size in children dialyzed with Hep-ACG vs RCA, no statistically significant differences were noted in gender, body mass, body height, or outcome, which means that the studied populations were mutually equivalent and relevantly representative for the current study. The patients treated with RCA demonstrated longer hospitalization in PICU, were younger, and, in view of the additional citrate flow, they received a higher dialysis dose in total than the children treated with Hep-ACG. In turn, when compared to the RCA group, the children treated with Hep-ACG were characterized by a more severe clinical status (which was evident in a higher number of vasopressor medications (VPS) at CRRT initiation and a higher absolute percentage of days with VPS administration during their PICU stay), required mechanical ventilatory support extending over a longer proportion of their PICU hospitalization and their urine output (UO) at the time of CRRT initiation was lower.
As shown in Tables 2 and 3 , 46% of the patients from the study population survived. There were no significant differences between the survivors and non-survivors with respect to age, weight, height, gender, number of days spent in PICU, estimated glomerular filtration rate (eGFR) value, urea concentration, total protein, albumin concentration at the start of CRRT, day of CRRT initiation, number of hours of CRRT per patient, dialysis dose per patient, ultrafiltration rate (UFR) value per patient, or ACT value.
On the other hand, as shown in Table 2 , the surviving children were subjected to CRRT mainly for AKI or FO% (as the immediate causes of CRRT initiation), required less intensive mechanical ventilatory support during their hospitalization in PICU, had fewer VPS at CRRT initiation, had a lower absolute percentage of days with VPS administration during their PICU stay, and had lower values of inflammatory marker (C-reactive protein (CRP)), but they maintained a significantly higher diuresis value at the time of CRRT initiation, which resulted in their mean degree of overhydration being 1.9 times lower on average. If the positive blood culture was not associated with sepsis, or with AKI and/or FO%, it also did not affect mortality in these patients. The only factor that was associated with a lower mortality was nephrological primary disease. Multi-organ failure occurred in 92% of the deceased children and it proved that the probability of death without MOF amounted to 13%, while the probability of death with MOF was 74%, thus being 5.7 times higher (mortality OR: 18.7; p < 0.001).
As shown in Table 2 , FO% showed significant differences between the surviving and deceased children. In the group of children with FO% <25% (n = 18), mortality amounted to 33.3% (n = 6), while in the group of children with FO% ≥25% (n = 28), mortality was more than 2-fold higher, amounting to 67.9% (n = 19, p < 0.001). Also, the analysis of the Kaplan-Meier curves (Fig. 1) showed that the survival outcomes worsened with FO% ≥25% at CRRT initiation.
The univariable logistic regression analysis demonstrated that significant effects on patient survival were exerted by FO% (OR: 1.030; confidence interval (CI) 95%: 1.001-1.059; p = 0.044), CRP value at CRRT initiation (OR: 1.078; CI 95%: 1.019-1.142; p = 0.009) and percentage of days with mechanical ventilatory support (OR: 1.068; CI 95%: 1.026-1.112; p = 0.001). This denoted that each 1% increase * Wilcoxon rank-sum test; ** Yates's modification of the χ 2 test; AKI -acute kidney injury; CRP -C-reactive protein; CRRT -continuous renal replacement therapy; eGFR -estimated glomerular filtration rate; FO% -fluid overload percentage; Hep-ACG -heparin anticoagulation; MOF -multi-organ failure; PICU -pediatric intensive care unit; QC -citrate flow rate; QD -dialyzate flow rate; QS -supplement flow rate; RCA -regional citrate anticoagulation; UO -urine output; VPS -vasopressors; SD -standard deviation; IQR -interquartile range; NS -not significant.
in FO% increased the odds of death by 3%, each 10 mg/L increase in CRP value increased the odds of death by 7.8% and each 1% increase in the percentage of mechanical ventilation increased the odds of death by 6.8%. In the case of the other parameters analyzed, including the volume of UO, eGFR, number of days spent in PICU, and number of hours of CRRT usage, no significant effect on patient survival was demonstrated.
The multivariable logistic regression for 2 input variables, CRP (OR: 1.098; CI 95%: 1.024-1.178; p = 0.009) and UO (OR: 0.404; CI 95%: 0.163-1.000; p = 0.050), indicated that with simultaneous consideration of both factors, each 10 mg/L increase in CRP with a constant UO value caused an increase in the odds of death by 9.8%, whereas each 1 mL/kg/h increase in UO with a constant CRP value caused a decrease in the odds of death by 59.6%.
Heparin anticoagulation was used significantly more frequently and for significantly longer periods in the deceased children, as compared to the group of survivors ( Table 3) . As shown in Table 3 , the mortality for Hep-ACG was 2.3 times higher than the mortality for RCA (0.66 vs 0.29), while the mortality OR demonstrated 4.8 times higher odds of death with the use of Hep-ACG vs RCA (the odds of death for a Hep-ACG and RCA patient were 21/11 = 1.91 * Wilcoxon rank-sum test; ** Yates's modification of the χ 2 test; AKI -acute kidney injury; CRP -C-reactive protein; CRRT -continuous renal replacement therapy; eGFR -estimated glomerular filtration rate; FO% -fluid overload percentage; Hep-ACG -heparin anticoagulation; MOF -multi-organ failure; PICU -pediatric intensive care unit; QC -citrate flow rate; QD -dialyzate flow rate; QS -supplement flow rate; RCA -regional citrate anticoagulation; SIMV -synchronized intermittent mandatory ventilation; UO -urine output; VPS -vasopressors; SD -standard deviation; IQR -interquartile range; NS -not significant. and 4/10 = 0.40, respectively; thus, the mortality OR was 1.91/0.40 = 4.8). Nevertheless, the number of VPS employed at the time of CRRT initiation and the absolute percentage of days with VPS administration during the PICU stay in the Hep-ACG group were significantly higher than in the RCA group (Table 1) ; thus, it may be concluded that the clinical status of the children treated with Hep-ACG was generally more severe compared to the RCA group, which is a probable reason of the higher mortality. While analyzing whether the employed ACG method might possibly affect the outcome, the multivariable analysis of the effect of FO% and the applied ACG mode on the survival rate was conducted. The data presented in Table 1 demonstrates that no significant difference was found in FO% values in the children dialyzed using the Hep-ACG vs RCA methods. On the other hand, as shown by the multivariable analysis of the effect of FO% and the applied ACG mode on survival rate, the only difference in survival was observed in the population of children dialyzed with Hep-ACG, while in the population of the RCA children, no significant difference was seen in mortality ( Table 4) .
The surviving children required a significantly higher Hep dosage, which means that the amount of the administered Hep was not associated with mortality, while the deceased children received a significantly higher citrate dosage, despite the fact that their CaT/CaI ratio was maintained within the normal range (Table 3) .
The mean and median values of FO% of the CRRT children since 2009 were high in comparison to the reported percentages in the literature. There was no difference in the duration of the PICU hospitalization between the CRRT patients (n = 46 (1.4%); mean ±SD/median (IQR): 21.9 ±19.9/17.5 (27.0)) and the rest of the PICU children hospitalized during the same period (n = 3,255; mean ±SD/median (IQR): 25.4 ±26.2/16.0 (24.0)). However, a significant difference was noted in the mortality between the 2 groups of patients (54% vs 6.5%; p < 0.001). * Wilcoxon rank-sum test; ACT -activated clotting time; BFR -blood flow rate; CaT/CaI -total calcium/ionic calcium index; CRRT -continuous renal replacement therapy; Hep-ACG -heparin anticoagulation; RCA -regional citrate anticoagulation; QC -citrate flow rate; QD -dialyzate flow rate; QS -supplement flow rate; UFR -ultrafiltration rate; SD -standard deviation; IQR -interquartile range; NS -not significant. 
Discussion
Continuous renal replacement therapy has become the treatment of choice for supporting critically ill patients with AKI. 17 Using a revised AKI definition, recent studies have indicated that up to 10% of all children admitted to PICUs suffer from some degree of kidney injury. 3 In accordance with the data from the literature, in the present study, the highest percentage of patients requiring CRRT included children with a primary diagnosis of a hematological/oncological disorder (56.5%) and children codiagnosed with MOF (67.4%).
In the literature, several factors have been identified as outcome predictors in the pediatric population requiring CRRT, including late CRRT initiation, hemodynamic instability, specified VPS number and dosage dependency, underlying diseases, low body weight, young age, need for mechanical ventilation, presence of MOF, and FO%. 5, 11, [18] [19] [20] [21] [22] [23] [24] [25] In our center, the surviving children required less intensive mechanical respiratory support, were administered a lower number of VPS at CRRT initiation, a lower absolute percentage of days with VPS administration during their PICU stay, and lower CRP values, but they maintained a significantly higher UO value on the day of CRRT initiation, which resulted in the degree of their overhydration at the initiation of CRRT being almost 2-fold lower on average. On the other hand, in the population of non-survivors, MOF as the immediate cause of CRRT initiation was significantly more common. According to the literature, MOF occurs in 30-50% of children in PICUs and is responsible for a higher percentage of total deaths. 26, 27 In a study by Hayes et al., a diagnosis of MOF was significantly associated with increased mortality, as it was present in 100% of non-survivors and in 69% of survivors. 22 Although in our center no significant differences were observed in the main diagnosis as a factor that might affect mortality, apart from purely nephrological causes, it was nevertheless demonstrated that the probability of death in the cases of concomitant MOF was almost 6 times higher.
Determining the therapeutic dose for CRRT in critically ill children remains a challenge. An analysis of a few randomized studies comparing a conventional vs intensive CRRT dose did not result in any differences in the outcomes (including kidney function and mortality) of PICU patients. 8, 28 In our center, no significant differences were noted in the dialysis dose between the survivors vs nonsurvivors, either.
There are numerous studies which prove that higher fluid accumulation is an independent risk factor of death in CRRT patients even after adjusting for severity of illness. 19, [21] [22] [23] The majority of studies indicate that a threshold of FO% equal to 20% is associated with a large increase in mortality. 8, 9 In the literature addressing FO% in pediatric CRRT, the average FO% was 16.4% in survivors and 34% in non-survivors, and the survival rate was 58% in those with FO% <20% as compared to 40% in those with FO% >20%, despite comparable illness severity scores. 11, 25 According to Sutherland et al., multivariable analysis suggested that each 1% increase in FO% was associated with a 3% increase in mortality OR. 21 In the current study, the mean values of FO% showed significant differences between the surviving children (24.1%) and non-survivors (45.0%). The cut-off value was assumed as FO% = 25%, which demonstrated that in the group of children with FO% <25%, the mortality was significantly more than 2-fold lower than in the group of children with FO% ≥25% (33.3% vs 67.9%). A worsening of the prognosis in the latter population of patients was also demonstrated by the analysis of the Kaplan-Meier curves (Fig. 1) . In addition, the univariable logistic regression analysis, as in the study conducted by Sutherland et al., confirmed that each increase in FO% by 1% increased the mortality OR by 3%. 21 In the current literature there are studies evaluating the efficacy and safety of RCA vs Hep-ACG in pediatric CRRT. These studies have shown that RCA is effective, provides equivalent circuit survival and decreases bleeding as compared to Hep-ACG. 29 In the studied population, treatment sessions were generally well tolerated by all patients.
Furthermore, in the literature, there are both studies reporting that there is no significant difference in mortality between the RCA (41.3%) and Hep-ACG (42.7%) groups, and studies, such as the one by Oudemans-van Straaten et al., proving that RCA appears particularly beneficial, especially after surgery, in sepsis and MOF (suggesting an interference with inflammation), reducing the overall probability of death. 13, [30] [31] [32] Although the data collected in our center suggests that the mortality in children dialyzed with Hep-ACG is more than 2-fold higher than the mortality while using the RCA mode, one should take into consideration the fact that the clinical status of children treated with Hep-ACG was in general more severe than the clinical status of the RCA group, which is undoubtedly the reason of their higher mortality. However, subsequent analyses comparing Hep-ACG with RCA in detail demonstrated that a significant effect on the outcome depending on the values of FO% occurred only in the group of children dialyzed using Hep-ACG.
A crucial factor in the discrepancy between the mortality of patients treated with the particular modes of ACG might be the fact that RCA in our center has been practically used only since the beginning of 2015, and that since that time virtually all (14/15) CRRT sessions were performed using this mode of ACG, which means that patients qualified to CRRT during that time were in a better general condition, which may reflect higher vigilance and awareness of the medical staff about the need for CRRT implementation in PICU patients, as well as better acquaintance with the CRRT technique itself.
In our center, CRRT is prescribed and handled by the nephrologists in collaboration with the PICU team. Nevertheless, since the onset of this technique in our center (2009), we have not observed a decrease in the degree of FO% or a significant difference in the day of initiation of this renal replacement mode.
According to the literature, mortality in PICU patients with secondary AKI requiring CRRT is high, being estimated at 35.6-60%; CRRT is required by about 5% of all PICU patients. 4, 18, 19, 21, 22, 24, 25, 33 Children with AKI at the time of admission are hospitalized twice as long as patients with normal renal function, while those who develop AKI during the PICU course have a 4-fold increase in the length of stay. 3 In our center, in the period 2009-2016, contrary to the data from the literature on the subject, the duration of PICU hospitalization did not significantly differ between the children who did and did not require CRRT, but the mortality in the former group was more than 8-fold higher, which confirmed the reports from the literature describing a poorer prognosis in those patients. 9 The authors are cognizant of some limitations of the study, as it was a retrospective, observational, single-center study, where interventions could not be standardized. Nevertheless, in the present study, a detailed analysis was performed of the course of PICU hospitalization of all 46 children who were subjected to this treatment technique since the onset of CRRT use in the center. In order to achieve the maximum homogeneity of the analyzed population, in view of the differing nature of AKI in such patients, the analysis did not include patients hospitalized in the cardiac surgery intensive care unit. The study provided a detailed characterization of practically all the factors that might affect the outcome in this population of patients, which is of high importance for future improvements in the quality of care of such patients.
Conclusions
The mortality of PICU patients who require CRRT is more than 8-fold higher than the mortality of the total PICU population. Coexisting MOF as the immediate cause of CRRT introduction increases the mortality almost 6 times. Apart from the patients' general clinical condition (which is reflected by the CRP values and the need for mechanical ventilation), only FO% exerts a significant negative effect on the survival of patients requiring CRRT. The mortality of children whose FO% at the time of CRRT initiation equals or exceeds 25% is almost 2-fold higher than the mortality of children whose FO% at the time of CRRT initiation does not exceed this value.
